Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorine-19 Gas MRI for Lung Ventilation in COPD
NCT01640288Phase 2Completed
- Sponsor
- Hal C Charles
- Start
- Jan 2013
- Primary completion
- Aug 2018
- Modality
- GAS (Genetic analysis systems)
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren in chronic obstructive pulmonary disease (COPD), sponsored by Hal C Charles. Started Jan 2013; status: completed.
02
Drugs
perflutren
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01640288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640288.